Impact of Biotin Supplementation on Human Chorionic Gonadotropin Immunoassays Utilizing Biotin-Streptavidin Binding Methods in Urine
Authors:
- 30 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 69 (7) , 754-762
Abstract
Background: Human chorionic gonadotropin (hCG) detection is indicative of pregnancy and can be indicative of some forms of cancerous tumors. The hCG drug itself, however, is a performance enhancing substance used by male athletes to increase testosterone production. Antidoping testing for hCG is conducted in urine, often on immunoanalyzer platforms, many of which utilize biotin-streptavidin dependent immunoassays in which the presence of biotin in samples is a known confounding factor. While biotin interference in serum has been well-studied, the extent of biotin interference in urine has not. Methods: Ten active male individuals underwent a 2-week hCG administration protocol concurrent with supplementation with biotin (20 mg/day) or placebo. Urine and serum samples were collected throughout the study and analyzed for hCG and biotin concentrations. Results: Urinary biotin levels in the hCG + biotin group increased 500-fold over baseline and 29-fold over corresponding serum biotin levels after biotin supplementation. When using a biotin-dependent immunoassay, the hCG + placebo group produced hCG-positive results (hCG ≥ 5 mIU/mL) in 71% of urine samples, while the hCG + biotin group produced positive results in only 19% of samples. Both groups had elevated hCG values in serum measurements by a biotin-dependent immunoassay and in urine when using a biotin-independent immunoassay. Urinary hCG measurements and biotin levels from the hCG + biotin group showed a negative correlation (Spearman r = −0.46, P < 0.0001) when measured using a biotin-dependent immunoassay. Conclusions: Biotin supplementation can severely suppress urinary hCG values in assays utilizing biotin-streptavidin binding methods and therefore these types of assays are not recommended for use in urine samples containing high levels of biotin. Clinicaltrials.gov Registration Number: NCT05450900Keywords
This publication has 22 references indexed in Scilit:
- The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone UseThe Journal of Sexual Medicine, 2015
- The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects2015
- Immunoextraction–Tandem Mass Spectrometry Method for Measuring Intact Human Chorionic Gonadotropin, Free β-Subunit, and β-Subunit Core Fragment in UrineClinical Chemistry, 2014
- Immuno–MS Based Targeted Proteomics: Highly Specific, Sensitive, and Reproducible Human Chorionic Gonadotropin Determination for Clinical Diagnostics and Doping AnalysisAnalytical Chemistry, 2012
- Falsely Decreased Human Chorionic Gonadotropin (hCG) Results Due to Increased Concentrations of the Free β Subunit and the β Core Fragment in Quantitative hCG AssaysClinical Chemistry, 2010
- The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference ReagentsClinica Chimica Acta, 2010
- Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic GonadotropinClinical Chemistry, 2009
- False-Negative Results in Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Due to Excess hCGβ Core FragmentClinical Chemistry, 2009
- Gonadotropins in doping: pharmacological basis and detection of illicit useBritish Journal of Pharmacology, 2008
- Serum concentrations of bisnorbiotin and biotin sulfoxide increase during both acute and chronic biotin supplementationJournal of Laboratory and Clinical Medicine, 1997